Crespo Blas Coll - 18 Sep 2024 Form 3 Insider Report for Structure Therapeutics Inc. (GPCR)

Role: Chief Medical Officer
Signature: /s/ Jun Yoon, Attorney-in-Fact
Issuer symbol: GPCR
Transactions as of: 18 Sep 2024
Net transactions value: $0
Form type: 3
Filing time: 20 Sep 2024, 17:41:12 UTC
Next filing: 03 Jul 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	GPCR	Ordinary Shares						12,000	18 Sep 2024	Direct	F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	GPCR	Share option (right to buy)							18 Sep 2024	Ordinary Shares	55,000	$2.79	Direct	F1, F3
holding	GPCR	Share option (right to buy)							18 Sep 2024	Ordinary Shares	100,020	$7.66	Direct	F1, F4
holding	GPCR	Share option (right to buy)							18 Sep 2024	Ordinary Shares	33,000	$11.75	Direct	F1, F5
holding	GPCR	American Depositary Shares							18 Sep 2024	Ordinary Shares	1,095		Direct	F1, F6
holding	GPCR	American Depositary Shares							18 Sep 2024	Ordinary Shares	3,000		By spouse	F1, F6

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents three Ordinary Shares of the Issuer.
F2	Represents restricted stock unit award granted under the Issuer's 2023 Equity Incentive Plan.
F3	One-fourth of the shares vested one year after May 16, 2022 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
F4	One-fourth of the shares vested one year after March 1, 2023 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
F5	One-fourth of the shares vest one year after March 1, 2024 (the "Vesting Commencement Date"); the balance of the shares vest in a series of 36 successive equal monthly installments measured from the first anniversary of the Vesting Commencement Date.
F6	Each ADS is convertible at any time, at the holder's election, into three Ordinary Shares of the Issuer. The ADSs have no expiration date.